GSK's Trading Volume Surges 61.27% to Rank 252nd Despite Stock Price Decline

On June 18, 2025, GSK's trading volume reached 3.02 billion, marking a 61.27% increase from the previous day. This surge placed GSK at the 252nd position in terms of trading volume for the day. However, despite the high trading volume, GSK's stock price fell by 2.72%, marking the fourth consecutive day of decline, with a total decrease of 9.06% over the past four days.

GSK's stock performance over the past six months has been notably strong, with a nearly 22% increase driven by robust growth in its Specialty Medicines division and a promising pipeline. This growth has been sustained despite challenges in the vaccine sector.

Analysts have revised their earnings estimates for GSK, with the consensus estimate for 2025 earnings rising from $4.26 to $4.42 per share, and for 2026 earnings increasing from $4.71 to $4.82 per share over the past 60 days. These upward revisions reflect growing confidence in the company's financial prospects.